نتایج جستجو برای: lipid lowering medications

تعداد نتایج: 232460  

Journal: :Journal of the American College of Cardiology 2005
Wissam A Jaber Ryan J Lennon Verghese Mathew David R Holmes Amir Lerman Charanjit S Rihal

OBJECTIVES We sought to determine whether the prescription of evidence-based medications at discharge after successful percutaneous coronary intervention (PCI) can predict long-term clinical outcome. BACKGROUND The association of standard-of-care drug utilization and long-term mortality and morbidity after PCI is not well studied. METHODS We performed a retrospective cohort study of success...

2017
Eric Adua Peter Roberts Samuel Asamoah Sakyi Francis Agyemang Yeboah Albert Dompreh Kwasi Frimpong Enoch Odame Anto Wei Wang

BACKGROUND Type II diabetes mellitus (T2DM) is complicated by multiple cardio-metabolic risk factors. Controlling these factors requires lifestyle modifications alongside utilisation of anti-diabetic medications. Different glucose lowering [(biguanides (BIGs), sulfonylureas (SUAs), thiazolidinediones (TNZ)], lipid lowering (statins), and anti-hypertensive medicines [angiotensin converting enzym...

Journal: :Archives of internal medicine 2007
Robert J Goldberg Frederick A Spencer Philippe Gabriel Steg Marcus Flather Gilles Montalescot Enrique P Gurfinkel Brian M Kennelly Shaun G Goodman Rebecca Dedrick Joel M Gore

BACKGROUND Current practice guidelines recommend the routine use of several effective cardiac medications in hospital survivors of acute myocardial infarction (AMI). METHODS We explored a recent 5-year (2000-2005) trend in hospital use of aspirin, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, lipid-lowering agents, and combinations thereof, in 26 413 adult men and women witho...

2015
Miriam Priglinger Hisatomi Arima Craig Anderson

Lipid-lowering therapy with 3-hydroxy-3methyl-glutarylCoA enzyme (HMG-CoA) reductase inhibitors (statins) is a proven effective treatment for prevention of ischemic vascular events. Controversy persists over whether statins increase the risk of intracerebral hemorrhage (ICH). A recent systematic overview of randomized trials found no association of statins and the risk of ICH, but less evidence...

Journal: :The Journal of the American Board of Family Medicine 1998

Journal: :Quality and Safety in Health Care 2006

Journal: :Journal of Internal Medicine 2001

Journal: :British Journal of Psychiatry 1997

Journal: :Atherosclerosis 2021

Exposure to low-density lipoprotein cholesterol (LDL-C) causes atherosclerotic cardiovascular disease (ASCVD) [[1]Ference B.A. Ginsberg H.N. Graham I. et al.Low-density lipoproteins cause disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement the European Atherosclerosis Society Consensus Panel.Eur. Heart J. 2017; 38: 2459-2472Crossref PubMed Scopus (983) ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید